Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 431 | 783 | 1,078 | 1,050 | 236 |
| Marketable Securities | N/A | N/A | N/A | N/A | 600 |
| Receivables | 79 | 116 | 60 | 318 | 116 |
| Inventories | 115 | 109 | 127 | 37 | 35 |
| TOTAL | $707 | $1,093 | $1,285 | $1,431 | $1,005 |
| Non-Current Assets | |||||
| PPE Net | 34 | 43 | 18 | 17 | 20 |
| Intangibles | 7 | N/A | 6 | 7 | N/A |
| TOTAL | $41 | $43 | $24 | $24 | $20 |
| Total Assets | $748 | $1,136 | $1,309 | $1,455 | $1,025 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | N/A | N/A | 188 | 229 | 213 |
| TOTAL | $141 | $282 | $188 | $229 | $213 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $N/A | $N/A | $N/A |
| Total Liabilities | $141 | $282 | $188 | $229 | $213 |
| Shareholders' Equity | |||||
| Retained earnings | -6,358 | -6,098 | -5,810 | -5,684 | -6,067 |
| TOTAL | $607 | $854 | $1,121 | $1,225 | $811 |
| Total Liabilities And Equity | $748 | $1,136 | $1,309 | $1,455 | $1,025 |